CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC’s AI
TOKYO, Mar 10, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) has announced that it will partner with the Nagasaki University DEJIMA Infectious Disease Research Alliance (Director: Prof. Kouichi Morita) for a research and development (R&D)
More